News

Two rival medical device companies specialising in scalp cooling technologies for cancer patients are merging to form a ...
MicroTransponder has posted one-year follow-up data for its FDA-approved device, two months after securing $65m in Series F ...
The US Food and Drug Administration (FDA) has set an "aggressive" timeline to implement genAI across the agency by 30 June ...
The IRB has granted approval for FastWave to initiate a coronary feasibility study leveraging its Sola L-IVL system.
Eye health company Bausch + Lomb has received the CE Mark approval in Europe for its LuxLife full range of vision intraocular ...
The National Institutes of Health (NIH) and the Centers for Medicare & Medicaid Services (CMS) are partnering to develop a ...
GeneDx has completed the acquisition of Fabric Genomics, a US-based company focused on AI-driven human genomic interpretation ...
HeartBeam has secured two new US patents, strengthening its intellectual property (IP) portfolio in cardiac monitoring ...
MedTech reveals that Europeans are generally willing to share their healthcare data in exchange for personalised treatment ...
Endogenex has shared results from its REGENT-1 clinical study during the Digestive Disease Week (DDW) 2025 event held in San ...
BrightHeart has gained a further 510(k) clearance from the FDA for its AI-based prenatal congenital heart defect (CHD) ...
Health Canada has approved Merit Medical Systems’ Wrapsody cell-impermeable endoprosthesis (CIE) device for haemodialysis ...